PRMT5 knockdown reactivates the RB1/RBL2-E2F tumor suppressor pathway and antagonizes cyclin D1-CDK4/6 signaling, which in turn leads to lymphoma cell death. The gene discussed is PRMT5; the disease is lymphoma.